Moderna
Breakthrough CMV vaccine offers hope to pregnant women
The vaccine, known as mRNA-1647, utilizes the same technology as Moderna's COVID-19 vaccines.
Health Ministry issues recommendation for Moderna COVID vaccine
Moderna says updated COVID vaccine is effective against newer variant
Moderna cancer vaccine with Merck's Keytruda delays return of deadly skin cancer
FDA to review COVID-19 shots for children, boosters this month
FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) panel will hold a meeting on Oct. 14 to discuss a booster dose of Moderna vaccine, and Johnson & Johnson on Oct. 15.
Heart inflammation rates higher after Moderna vaccine - Canada data
Reported cases of rare heart inflammation were relatively higher after Moderna's COVID-19 vaccine compared with the Pfizer/BioNTech shots. The majority of the affected individuals recovered quickly.
COVID pandemic will be over within a year - Moderna CEO
Bancel stated that the world will return to routine life by this time next year.
Which COVID vaccine is most effective against hospitalization?
A new study found that Moderna and Pfizer vaccines were found to keep adults out of the hospital over Johnson & Johnson.
Cause of Japan Moderna vaccine contamination likely found
Japan's health minister said the contamination that led to the suspension of millions of doses of COVID vaccine in Okinawa was likely caused when needles were incorrectly inserted into vials.
Japan: One million Moderna shots withdrawn after two die
Some think it unlikely that the contaminated vaccines caused the death of two people in Japan, saying the death count would be higher if the contamination was really dangerous enough to kill.
Moderna’s outgoing Israeli chief medical officer joins TEVA board
Dr. Tal Zaks will serve on the Teva board's science and technology committee.
Two dead from Moderna's contaminated COVID vaccines in Japan
Japan halted the use of 1.63 million Moderna doses shipped to 863 vaccination centers nationwide after receiving reports of contaminants in some vials.
EU: Moderna production can resume after metal contamination
News of the contaminant could provide a fresh setback for Japan's inoculation drive as it struggles to persuade many - particularly young people - to get vaccinated.
Moderna: COVID-19 shot 93% effective six months after second dose
"Our COVID-19 vaccine is showing durable efficacy of 93% through six months, but recognize that the Delta variant is a significant new threat so we must remain vigilant."